Literature DB >> 24743376

Effects of the trace amine-associated receptor 1 agonist RO5263397 on abuse-related effects of cocaine in rats.

David A Thorn1, Li Jing2, Yanyan Qiu1, Amy M Gancarz-Kausch1, Chad M Galuska3, David M Dietz1, Yanan Zhang4, Jun-Xu Li1.   

Abstract

Animal knockout studies suggest that trace amine-associated receptor (TAAR) 1 is involved in behavioral effects of psychostimulants such as cocaine. Recently, several highly selective TAAR 1 agonists have been discovered. However, little is known of the impact of TAAR 1 agonists on abuse-related effects of cocaine. Here, we report the effects of a TAAR 1 agonist RO5263397 on several abuse-related behavioral effects of cocaine in rats. RO5263397 was evaluated for its effects on cocaine-induced behavioral sensitization, conditioned place preference (CPP), cue- and cocaine prime-induced reinstatement of cocaine-seeking behavior, and cocaine self-administration using behavioral economic analysis. RO5263397 reduced the expression of cocaine behavioral sensitization, cue- and cocaine prime-induced reinstatement of cocaine seeking, and expression but not development of cocaine CPP. Behavioral economic analysis showed that RO5263397 increased the elasticity of the cocaine demand curve, but did not change cocaine consumption at minimal prices. Taken together, this is the first systematic assessment of a TAAR 1 agonist on a range of behavioral effects of cocaine, showing that RO5263397 was efficacious in reducing cocaine-mediated behaviors. Collectively, these data uncover essential neuromodulatory roles of TAAR 1 on cocaine abuse, and suggest that TAAR 1 may represent a novel drug target for the treatment of cocaine addiction.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24743376      PMCID: PMC4138753          DOI: 10.1038/npp.2014.91

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  38 in total

1.  Pharmacotherapy and other treatments for cocaine abuse and dependence.

Authors:  Frank J Vocci; Ahmed Elkashef
Journal:  Curr Opin Psychiatry       Date:  2005-05       Impact factor: 4.741

2.  Between-session progressive ratio performance in rats responding for cocaine and water reinforcers.

Authors:  Amy M Gancarz; Michael A Kausch; David R Lloyd; Jerry B Richards
Journal:  Psychopharmacology (Berl)       Date:  2012-01-27       Impact factor: 4.530

Review 3.  Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure.

Authors:  David H Epstein; Kenzie L Preston; Jane Stewart; Yavin Shaham
Journal:  Psychopharmacology (Berl)       Date:  2006-09-22       Impact factor: 4.530

Review 4.  Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues.

Authors:  T M Tzschentke
Journal:  Prog Neurobiol       Date:  1998-12       Impact factor: 11.685

5.  Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors.

Authors:  Jack Bergman; Rebecca A Roof; Cheryse A Furman; Jennie L Conroy; Nancy K Mello; David R Sibley; Phil Skolnick
Journal:  Int J Neuropsychopharmacol       Date:  2012-07-25       Impact factor: 5.176

6.  Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor.

Authors:  J R Bunzow; M S Sonders; S Arttamangkul; L M Harrison; G Zhang; D I Quigley; T Darland; K L Suchland; S Pasumamula; J L Kennedy; S B Olson; R E Magenis; S G Amara; D K Grandy
Journal:  Mol Pharmacol       Date:  2001-12       Impact factor: 4.436

7.  A comparison of economic demand and conditioned-cued reinstatement of methamphetamine-seeking or food-seeking in rats.

Authors:  Chad M Galuska; Kelly M Banna; Lena Vaughn Willse; Noushin Yahyavi-Firouz-Abadi; Ronald E See
Journal:  Behav Pharmacol       Date:  2011-08       Impact factor: 2.293

8.  The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system.

Authors:  Amyaouch Bradaia; Gerhard Trube; Henri Stalder; Roger D Norcross; Laurence Ozmen; Joseph G Wettstein; Audrée Pinard; Danièle Buchy; Martin Gassmann; Marius C Hoener; Bernhard Bettler
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-05       Impact factor: 11.205

9.  The cannabinoid CB1 receptor antagonist AM251 does not modify methamphetamine reinstatement of responding.

Authors:  Sherin Y Boctor; Joe L Martinez; Wouter Koek; Charles P France
Journal:  Eur J Pharmacol       Date:  2007-06-13       Impact factor: 4.432

10.  Substituted tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor.

Authors:  David A Perrey; Nadezhda A German; Brian P Gilmour; Jun-Xu Li; Danni L Harris; Brian F Thomas; Yanan Zhang
Journal:  J Med Chem       Date:  2013-08-26       Impact factor: 7.446

View more
  41 in total

1.  Effect of 1-substitution on tetrahydroisoquinolines as selective antagonists for the orexin-1 receptor.

Authors:  David A Perrey; Nadezhda A German; Ann M Decker; David Thorn; Jun-Xu Li; Brian P Gilmour; Brian F Thomas; Danni L Harris; Scott P Runyon; Yanan Zhang
Journal:  ACS Chem Neurosci       Date:  2015-02-12       Impact factor: 4.418

2.  E3 Ubiquitin-Protein Ligase SMURF1 in the Nucleus Accumbens Mediates Cocaine Seeking.

Authors:  Craig T Werner; Rathipriya Viswanathan; Jennifer A Martin; Pedro H Gobira; Swarup Mitra; Shruthi A Thomas; Zi-Jun Wang; Jian-Feng Liu; Andrew F Stewart; Rachael L Neve; Jun-Xu Li; Amy M Gancarz; David M Dietz
Journal:  Biol Psychiatry       Date:  2018-07-21       Impact factor: 13.382

3.  Trace amines and cocaine abuse.

Authors:  Jun-Xu Li
Journal:  ACS Chem Neurosci       Date:  2014-05-21       Impact factor: 4.418

4.  Discovery and Characterization of 2-Aminooxazolines as Highly Potent, Selective, and Orally Active TAAR1 Agonists.

Authors:  Guido Galley; Angélica Beurier; Guillaume Décoret; Annick Goergler; Roman Hutter; Susanne Mohr; Axel Pähler; Philipp Schmid; Dietrich Türck; Robert Unger; Katrin Groebke Zbinden; Marius C Hoener; Roger D Norcross
Journal:  ACS Med Chem Lett       Date:  2015-12-30       Impact factor: 4.345

5.  TAAR1 Modulates Cortical Glutamate NMDA Receptor Function.

Authors:  Stefano Espinoza; Gabriele Lignani; Lucia Caffino; Silvia Maggi; Ilya Sukhanov; Damiana Leo; Liudmila Mus; Marco Emanuele; Giuseppe Ronzitti; Anja Harmeier; Lucian Medrihan; Tatyana D Sotnikova; Evelina Chieregatti; Marius C Hoener; Fabio Benfenati; Valter Tucci; Fabio Fumagalli; Raul R Gainetdinov
Journal:  Neuropsychopharmacology       Date:  2015-03-09       Impact factor: 7.853

6.  Trace amine-associated receptor 1 agonists RO5263397 and RO5166017 attenuate quinpirole-induced yawning but not hypothermia in rats.

Authors:  Justin N Siemian; Yanan Zhang; Jun-Xu Li
Journal:  Behav Pharmacol       Date:  2017-10       Impact factor: 2.293

Review 7.  TAAR1 and Psychostimulant Addiction.

Authors:  Jianfeng Liu; Ruyan Wu; Jun-Xu Li
Journal:  Cell Mol Neurobiol       Date:  2020-01-23       Impact factor: 5.046

8.  TAAR1 agonists attenuate extended-access cocaine self-administration and yohimbine-induced reinstatement of cocaine-seeking.

Authors:  Jianfeng Liu; Bernard Johnson; Ruyan Wu; Robert Seaman; Jimmy Vu; Qing Zhu; Yanan Zhang; Jun-Xu Li
Journal:  Br J Pharmacol       Date:  2020-05-05       Impact factor: 8.739

9.  Antinociceptive effects of imidazoline I2 receptor agonists in the formalin test in rats.

Authors:  David A Thorn; Yanyan Qiu; Shushan Jia; Yanan Zhang; Jun-Xu Li
Journal:  Behav Pharmacol       Date:  2016-06       Impact factor: 2.293

10.  Trace Amine-Associated Receptor 1 Regulates Wakefulness and EEG Spectral Composition.

Authors:  Michael D Schwartz; Sarah W Black; Simon P Fisher; Jeremiah B Palmerston; Stephen R Morairty; Marius C Hoener; Thomas S Kilduff
Journal:  Neuropsychopharmacology       Date:  2016-09-23       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.